Wolverine Trading, LLC Aldeyra Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$2.77 - $4.22 $30,747 - $46,842	11,100 New	11,100 $36,000
Q2 2023 Aug 23, 2023	BUY	$7.11 - $11.89 $65,412 - $109,388	9,200 Added 33.21%	36,900 $309,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $69,240 - $119,160	12,000 Added 76.43%	27,700 $263,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $23,876 - $33,323	4,700 Added 42.73%	15,700 $109,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $41,800 - $85,140	11,000 New	11,000 $58,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.